CD30-CD30 Ligand Interaction in Primary Cutaneous CD30+T-Cell Lymphomas: A Clue to the Pathophysiology of Clinical Regression

Blood - United States
doi 10.1182/blood.v94.9.3077.421k28_3077_3083
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Primary Cutaneous CD30+ Anaplastic Large T Cell Lymphoma. A Series of Nine Cases

Gaceta Medica de Mexico
Medicine
2019English

CD30+ Primary Cutaneous Post-Transplant Lymphoproliferative Disorder With Signet-Ring Cell Features

Hematology Reports
Hematology
2016English

Primary Cutaneous CD30-positive Large T-Cell Lymphoma With Secondary Lymph Node Involvement Detected by Sentinel Lymphonodectomy

Acta Dermato-Venereologica
DermatologyMedicine
2002English

Engagement of CD153 (CD30 Ligand) by CD30+ T Cells Inhibits Class Switch DNA Recombination and Antibody Production in Human IgD+ IgM+ B Cells

Journal of Immunology
AllergyImmunology
2000English

Final Data From the Phase 3 Alcanza Study: Brentuximab Vedotin (Bv) vs Physician's Choice (Pc) in Patients (Pts) With Cd30-Positive (Cd30+) Cutaneous T-Cell Lymphoma (Ctcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Challenges of Driving CD30-directed CAR-T Cells to the Clinic

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

CD30-Antikörper-Konjugat Schafft Durchbruch

Info Onkologie
2013English

SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated With a T-Helper-17 Cytokine Profile

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy